|
⚲
|
| Keyboard |
| Tufts Linda
✚
|
|
|---|---|
| CIK # | 0001388680 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001388680] | |
| 4 | [0001388680] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| PhaseBio Pharmaceuticals Inc | |
| Tufts Linda |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
PhaseBio Pharmaceuticals Inc PHAS
Non-employee Director Stock Option (right to buy) · derivative
|
2019-02-27 | Grant | 36,000 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 58,152 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 1,277 | $5.00 | 6,385 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 275,055 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 6,041 | $5.00 | 30,205 |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Conversion | 577,486 | ||
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 165,395 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 47,140 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 4,746 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series C-1 Preferred Stock · derivative
|
2018-10-22 | Conversion | 22,452 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 63,688 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 6,413 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series D Preferred Stock · derivative
|
2018-10-22 | Conversion | 30,334 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 7,053 | $0.12 | 846 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Sell | 170 | $5.00 | 850 |
|
PhaseBio Pharmaceuticals Inc PHAS
Warrants to Purchase Series B Preferred Stock · derivative
|
2018-10-22 | Option exercise | 710 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 34,968 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Series B Preferred Stock · derivative
|
2018-10-22 | Conversion | 347,250 | $0.00 | |
|
PhaseBio Pharmaceuticals Inc PHAS
Common Stock
|
2018-10-22 | Buy | 12,682 | $5.00 | 63,410 |
|
PhaseBio Pharmaceuticals Inc PHAS
Series AA Preferred Stock · derivative
|
2018-10-22 | Conversion | 12,025 | $0.00 | |
| showing 20 of 37 most recent transactions | |||||